Open Call#2 for Accelerating Data-Driven Solutions to Save Lives from COVID-19

The consortium of COVID-X announces the launch of Open Call #2 for a unique acceleration programme in Europe to fast-track to market 15+ European data technology solutions, addressing COVID-19 challenges and facilitating an innovative stack of AI-driven tools in order to defeat the pandemic.

COVID-X Programme, supported by the European Commission under Horizon2020 programme, funds European companies and healthcare providers to boost 30+ data-driven solutions to the markets to overcome clinical challenges in diagnosis, prognosis, and follow-up. The funding is invested in solutions with TRL 7+ and [or in the process of] CE marking, covering two profiles: single solution (EU tech SMEs / Start-Ups) validating their solutions at one of COVID-X pilot sites; or team solution (Tech provider bringing in a healthcare provider that will validate the solution).

In addition to the direct funding, the COVID-X Programme provides the top-ranked solutions access in a tailored acceleration programme organized in 3 sprints of 3 months each. These include technical coaching, business mentoring sessions as well as support in ethical issues and piloting with healthcare organizations. This 10-month programme targets to boost the quick market uptake to defeat COVID-19 with data solutions.

To attract top-notch solutions meeting the set selection criteria, the Open Call#2 has a two-stage application process: In the first stage, the applicant's eligibility and alignment with the selection criteria are assessed. All eligible applications access the 2nd stage where the complete application form with detailed information about the solution & implementation is required.

The COVID-X Programme Open Call #1 closed on 27.1.2021 gathering 112 applications from data technology companies and healthcare providers coming from 29 different countries in Europe and beyond. 16 selected single and team solutions were selected and are now completing the 1st Sprint of the programme.

The Open Call#2 application is now open and the deadline for the first stage will be on the 22nd of July 2021. (17:00PM CEST).

For further infromation, please visit:
https://www.covid-x.eu/apply-now/

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...